Annual Total Debt
$41.53 M
-$403.23 M-90.66%
31 December 2023
Summary:
Supernus Pharmaceuticals annual total debt is currently $41.53 million, with the most recent change of -$403.23 million (-90.66%) on 31 December 2023. During the last 3 years, it has fallen by -$372.80 million (-89.98%). SUPN annual total debt is now -90.66% below its all-time high of $444.76 million, reached on 31 December 2022.SUPN Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$38.15 M
-$1.82 M-4.56%
30 September 2024
Summary:
Supernus Pharmaceuticals quarterly total debt is currently $38.15 million, with the most recent change of -$1.82 million (-4.56%) on 30 September 2024. Over the past year, it has dropped by -$4.17 million (-9.85%). SUPN quarterly total debt is now -92.73% below its all-time high of $524.95 million, reached on 31 March 2023.SUPN Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SUPN Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -90.7% | -9.8% |
| 3 y3 years | -90.0% | -90.9% |
| 5 y5 years | -87.4% | -89.7% |
SUPN Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -90.7% | at low | -92.7% | at low |
| 5 y | 5 years | -90.7% | at low | -92.7% | at low |
| alltime | all time | -90.7% | -92.7% |
Supernus Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $38.15 M(-4.6%) |
| June 2024 | - | $39.98 M(-5.1%) |
| Mar 2024 | - | $42.13 M(+1.4%) |
| Dec 2023 | $41.53 M(-90.7%) | $41.53 M(-1.9%) |
| Sept 2023 | - | $42.32 M(+0.3%) |
| June 2023 | - | $42.20 M(-92.0%) |
| Mar 2023 | - | $524.95 M(+18.0%) |
| Dec 2022 | $444.76 M(+4.2%) | $444.76 M(+0.1%) |
| Sept 2022 | - | $444.22 M(-0.2%) |
| June 2022 | - | $445.03 M(-0.3%) |
| Mar 2022 | - | $446.41 M(+4.5%) |
| Dec 2021 | $427.03 M(+3.1%) | $427.03 M(+2.2%) |
| Sept 2021 | - | $417.95 M(+1.3%) |
| June 2021 | - | $412.43 M(-1.2%) |
| Mar 2021 | - | $417.31 M(+0.7%) |
| Dec 2020 | $414.32 M(+9.5%) | $414.32 M(+0.2%) |
| Sept 2020 | - | $413.69 M(+1.0%) |
| June 2020 | - | $409.60 M(+6.8%) |
| Mar 2020 | - | $383.49 M(+1.3%) |
| Dec 2019 | $378.44 M(+14.9%) | $378.44 M(+1.8%) |
| Sept 2019 | - | $371.56 M(+0.9%) |
| June 2019 | - | $368.10 M(+1.0%) |
| Mar 2019 | - | $364.38 M(+10.6%) |
| Dec 2018 | $329.46 M(>+9900.0%) | $329.46 M(+1.2%) |
| Sept 2018 | - | $325.67 M(+1.2%) |
| June 2018 | - | $321.92 M(+1.2%) |
| Mar 2018 | - | $318.23 M(>+9900.0%) |
| Dec 2017 | $0.00 | $0.00(0.0%) |
| Sept 2017 | - | $0.00(-100.0%) |
| June 2017 | - | $1.47 M(-55.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $3.31 M(-20.5%) |
| Dec 2016 | $4.17 M(-41.2%) | $4.17 M(-27.8%) |
| Sept 2016 | - | $5.77 M(+1.3%) |
| June 2016 | - | $5.70 M(+1.3%) |
| Mar 2016 | - | $5.63 M(-20.6%) |
| Dec 2015 | $7.08 M(-73.0%) | $7.08 M(-12.2%) |
| Sept 2015 | - | $8.07 M(-7.9%) |
| June 2015 | - | $8.76 M(-25.2%) |
| Mar 2015 | - | $11.71 M(-55.4%) |
| Dec 2014 | $26.22 M(-23.8%) | $26.22 M(-1.0%) |
| Sept 2014 | - | $26.50 M(-7.6%) |
| June 2014 | - | $28.67 M(+1.1%) |
| Mar 2014 | - | $28.36 M(-17.5%) |
| Dec 2013 | $34.39 M(+50.2%) | $34.39 M(-42.8%) |
| Sept 2013 | - | $60.17 M(+1.8%) |
| June 2013 | - | $59.10 M(+193.9%) |
| Mar 2013 | - | $20.11 M(-12.2%) |
| Dec 2012 | $22.90 M(-22.3%) | $22.90 M(-10.6%) |
| Sept 2012 | - | $25.61 M(-7.9%) |
| June 2012 | - | $27.81 M(-4.4%) |
| Mar 2012 | - | $29.10 M(-1.3%) |
| Dec 2011 | $29.49 M(>+9900.0%) | $29.49 M(-67.1%) |
| Sept 2011 | - | $89.51 M(>+9900.0%) |
| June 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2010 | - | $75.00 M(0.0%) |
| Dec 2009 | $75.00 M(0.0%) | $75.00 M |
| Dec 2008 | $75.00 M(>+9900.0%) | - |
| Dec 2007 | $0.00 | - |
FAQ
- What is Supernus Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual total debt year-on-year change?
- What is Supernus Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly total debt year-on-year change?
What is Supernus Pharmaceuticals annual total debt?
The current annual total debt of SUPN is $41.53 M
What is the all time high annual total debt for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual total debt is $444.76 M
What is Supernus Pharmaceuticals annual total debt year-on-year change?
Over the past year, SUPN annual total debt has changed by -$403.23 M (-90.66%)
What is Supernus Pharmaceuticals quarterly total debt?
The current quarterly total debt of SUPN is $38.15 M
What is the all time high quarterly total debt for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly total debt is $524.95 M
What is Supernus Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, SUPN quarterly total debt has changed by -$4.17 M (-9.85%)